MikeTrendsTrends right now

search

FDA

Trends

  1. 1
    E. coli outbreak linked to raw milk cheese sickens 13 across USโ—E. coli outbreak linked to raw milk cheese leads to 13 illnesses and eight hospitalizations across the US: FDAโœ‰newsHealthPandemics11 min ago

    Federal health officials are investigating an E. coli outbreak tied to raw milk cheese that has sickened 13 people across the United States, according to the FDA. Eight of those affected required hospitalization. The agency has not detailed which cheese products or brands are involved, and consumers are being advised to watch for updates as the investigation continues.

  2. 2

    The FDA has announced a recall of raw milk cheese linked to an E. coli outbreak. Multiple US news outlets, including DC News Now, WTNH and NewsNation, are reporting the recall, which affects consumers who may have purchased the cheese. Health officials typically urge anyone with symptoms of E. coli infection, such as severe stomach cramps and diarrhea, to seek medical attention. Further details about the brand and affected states have not been provided in early reports.

  3. 3
    FDA links Ecuadorian black clams to hepatitis A outbreakโ—FDA warns black clams from Ecuador tied to hepatitis A outbreak, 30 hospitalizedโœ‰newsHealthPandemics11 min ago

    The FDA is warning consumers about black clams imported from Ecuador after they were tied to an outbreak of hepatitis A that has left 30 people hospitalized. Health officials are urging anyone who may have eaten the clams to watch for symptoms such as jaundice, fatigue and abdominal pain, and investigators are working to trace the contaminated shellfish and prevent further sales.

  4. 4
    Thyroid medicine recall flagged as FDA's highest riskโ—Thyroid medicine recall classified under FDA's highest risk level https:// blog.taursnd.haus/display/1a04 1b09-206a-b7caMmastodonHealthMedicine316 min ago

    A thyroid medication has been recalled and the recall has been classified at the FDA's most serious risk level, meaning the agency considers the issue potentially life-threatening. The announcement is drawing attention as patients who rely on thyroid medicine are urged to check whether their supply is affected and follow FDA guidance on returning or replacing it.

  5. 5

    Disc Medicine, a clinical-stage biotech company, is facing investor investigations following an FDA letter that raised concerns for shareholders. Law firms have reportedly begun looking into whether the company misled investors about its regulatory prospects. The development puts pressure on the stock and adds uncertainty to the company's drug approval timeline, drawing attention from biotech investors tracking FDA-related setbacks.